Another weight loss pill approved by FDA
Digest more
The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients.
A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition,
The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.
Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.
In TODAY.com's Expert Tip of the Day, a dietitian shares the dieting red flag she looks for in a weight loss program.